Alpha-synuclein as a potential biomarker for Parkinson’s disease progression

Takeaway

  • Compared with healthy individuals, the alpha-synuclein (α-syn) levels in neurons of people with Parkinson’s disease (PD) was significantly higher.

Why this matters

    Identification of biomarkers for early diagnosis of PD can lead to improved standards of care.